Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Lycopodium alkaloids.

Xiaoqiang Ma1, David R Gang

  • 1Department of Plant Sciences and Bio5 Institute, University of Arizona, 303 Forbes Building, Tucson, AZ 85721-0036, USA.

Natural Product Reports
|November 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated network toxicology and experimental validation to investigate potential mechanisms associated with aspartame-induced malignant phenotypic changes in colorectal cancer.

Naunyn-Schmiedeberg's archives of pharmacology·2026
Same author

A microbial platform for selective biosynthesis of monoterpene esters.

Nature communications·2026
Same author

Microbial Biosynthesis of Monoterpenoic Acid from Glycerol.

Biotechnology journal·2026
Same author

A modular single- and dual-gene expression toolkit for Kluyveromyces marxianus.

World journal of microbiology & biotechnology·2026
Same author

Zexie-Baizhu herb pair attenuates MASH via the gut-liver Axis by suppressing NLRP3 Inflammasome activation and M1-macrophage polarization.

Bioorganic chemistry·2026
Same author

Short-Term Effects of Maternal Cannabis Use on Human Milk Macronutrient Composition: The Lactation and Cannabis (LAC) Study.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine·2025
Same journal

Inhibitors of nutrient pathways: nature's overlooked antibiotic arsenal.

Natural product reports·2026
Same journal

Challenges in the complexity-to-diversity strategy for natural product-like compound synthesis: two sides of the same coin.

Natural product reports·2026
Same journal

SAM-dependent methyltransferases: from chemoenzymatic natural product synthesis to industrial application.

Natural product reports·2026
Same journal

Visual cycle-derived bisretinoids as endogenous natural products: enzyme-free formation, photochemical reactivity, and retinal degeneration.

Natural product reports·2026
Same journal

Non-strigolactone natural products interfering with parasitic weed development.

Natural product reports·2026
Same journal

Biosynthetic crosstalk in bacteria: routes to chimeric natural products.

Natural product reports·2026
See all related articles

Lycopodium alkaloids, including Huperzine A (HupA), show potential for treating Alzheimer's disease by inhibiting acetylcholinesterase. This review covers their chemistry, pharmacology, and clinical research, focusing on HupA

Area of Science:

  • Natural Product Chemistry
  • Pharmacology
  • Medicinal Chemistry

Background:

  • Lycopodium alkaloids are a diverse group of natural products, some exhibiting potent acetylcholinesterase (AChE) inhibitory activity.
  • Huperzine A (HupA), a prominent Lycopodium alkaloid, has demonstrated cognitive-enhancing effects in animal models and holds promise for Alzheimer's disease (AD) treatment.
  • Over 200 Lycopodium alkaloids from 54 species have been identified, with significant research interest in their therapeutic potential.

Purpose of the Study:

  • To comprehensively review the chemical, pharmacological, and clinical research on Lycopodium alkaloids published between 1993 and 2004.
  • To analyze the structures, classifications, and biogenetic relationships of major Lycopodium alkaloid groups.
  • To summarize the bioactivities, particularly the acetylcholinesterase inhibitory effects, and explore structure-activity relationships of HupA and its analogs.

Related Experiment Videos

Main Methods:

  • Literature review of chemical, pharmacological, and clinical studies on Lycopodium alkaloids.
  • Structural elucidation and classification of newly identified alkaloids.
  • Comparison of HupA's effects on AChE and butylcholine esterase with other cholinesterase inhibitors.
  • Analysis of clinical trial data and plant propagation techniques for HupA.

Main Results:

  • 81 new Lycopodium alkaloid structures were identified, classified, and analyzed.
  • The review details structural characteristics and biogenetic relationships of four major alkaloid groups.
  • HupA and other cholinesterase inhibitors were compared for their effects on AChE and butylcholine esterase activity.
  • Clinical trial information for HupA and its derivative ZT-1 was presented, alongside propagation advancements.

Conclusions:

  • Lycopodium alkaloids, especially Huperzine A, represent a significant class of compounds with therapeutic potential for Alzheimer's disease.
  • Further research into structure-activity relationships and biosynthetic pathways can optimize the development of novel anti-AD agents.
  • Advancements in plant propagation offer potential for sustainable sourcing of HupA.